FREMONT, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced that its NULISA™ platform will be featured in more than 140 poster and session presentations at the Alzheimer's Association International Conference (AAIC), taking place July 12-15 in London. The volume of data reflects widespread adoption of NULISA and ARGO™ HT technology among researchers studying Alzheimer’s and related dementias.
Read more at globenewswire.comAlamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Barchart·07/10/2026 05:11:00
语音播报
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.